HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Miyachi, K. Articles by Okuda, K. Search for Related Content PubMed PubMed Citation Articles by Miyachi, K. Articles by Okuda, K.

Arg-gingipain A DNA Vaccine Prevents Alveolar Bone Loss in Mice

¹ Department of Microbiology and
² Oral Health Science Center, Tokyo Dental College, 1-2-2 Masago, Mihama-ku, Chiba, 261-8502, Japan

^* corresponding author, ishihara{at}tdc.ac.jp

One major pathogenic factor of Porphyromonas gingivalis is Arg-gingipain (Rgp), an arginine-specific cysteine proteinase. To clarify the effect of rgpA DNA vaccine, we immunized BALB/c mice via the abdomen with a Gene Gun or via the nasal cavity weekly for 6 weeks. After immunization, the mice were challenged orally with P. gingivalis. Immunization elicited IgG responses against P. gingivalis in both groups. Nasal immunization also induced sIgA against P. gingivalis, although Gene Gun immunization did not. Reduction of alveolar bone loss was observed in both groups at 42 days following initial infection. This effect was more pronounced in the intranasal immunization group than in the Gene Gun group. The results of this study suggest that immunization with rgpA DNA vaccine via the nasal cavity is an effective method for preventing alveolar bone loss incurred by infection with P. gingivalis.

KEY WORDS: Porphyromonas gingivalis • vaccine • periodontitis • bone loss • mucosal immunity